All In Biotech

Drug Trial Radar · NCT01045980

Assessment of Bioimpedance and Vitamin D and LV Mass in PD Patients (FLUID Study)

The Effect of Bio-impedance Analysis and Vitamin D Versus Usual Care on Left Ventricular Mass in Peritoneal Dialysis Patients: a Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: May 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

74

Actual

Start

Aug 1, 2010

Primary completion

May 15, 2016

Study completion Nov 30, 2016

Sponsor

Lead sponsor
St. Joseph's Healthcare HamiltonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Population Health Research Institute
First posted
Jan 11, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Factorial
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to compare the effects of using bio-impedance analysis to guide management of fluid status versus routine clinical care on heart structure. In addition, Vitamin D is being assessed to determine its effect on heart structure.

Conditions

  • Disorders Associated With Peritoneal Dialysis

Interventions

  • Bioimpedance and Vitamin DDrug

    Intervention subjects will undergo BIA assessment monthly for 1 year, and then every 3 months until the end of the planned 3-year study. Protocolized interventions to achieve euvolemia will occur based on the BIA result and they include sodium restriction, addition of diuretics, use of icodextrin, and additional rational changes to the PD prescription.

  • Usual care and placeboDrug

    Usual care (not bioimpedance guided volume management) and Placebo

  • Usual care and Vitamin DDrug

    Usual care (not bioimpedance guided volume management) and Vitamin D

  • Bioimpedance and PlaceboDevice

    Bioimpedance guided volume management and Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Left ventricular mass measured by cardiac MRITime frame: 1 year

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • St. Joseph's Healthcare Hamilton

    Hamilton, Ontario, Canada

  • Population Health Research Institute - McMaster University

    Hamilton, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.